Lazertinib
- Generic Name
- Lazertinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C30H34N8O3
- CAS Number
- 1903008-80-9
- Unique Ingredient Identifier
- 4A2Y23XK11
- Background
Lazertinib is under investigation in clinical trial NCT04487080 (A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-small Cell Lung Cancer).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath